Safety

FDA Action on Loperamide Misuse; Plus Phase 1 Trials for BAT2506 Biosimilar Begin

November 20, 2019 • By Michele B. Kaufman, PharmD, BCGP

urfin / shutterstock.com

How to Improve Opioid Prescribing in an Outpatient Clinic

October 18, 2019 • By Lisa Carnago, FNP, Jenelle Hall, PharmD, & Stephanie Puryear, RMA

phichet chaiyabin / shutterstock.com

Measles Is Back. How Does This Affect Patients with Rheumatic Disease?

August 16, 2019 • By Ruth Jessen Hickman, MD

FDA Approves Risankizumab, Adds Stronger Warning to Sleep Medications

May 29, 2019 • By Michele B. Kaufman, PharmD, BCGP

FDA Issues Boxed Warning for Febuxostat & Approves Colchicine for Gout Flare

March 12, 2019 • By Michele B. Kaufman, PharmD, BCGP

Safety Risk with Higher Dose Tofacitnib

March 6, 2019 • By Michele B. Kaufman, PharmD, BCGP

FDA Update: Priority Review for Non-Opioid Treatment & New Warning for Fluoroquinolones

January 23, 2019 • By Michele B. Kaufman, PharmD, BCGP

ah_designs / shutterstock.com

The Perils of Pain Meds Revisited

December 18, 2018 • By Stephen G. Gelfand, MD, FACP, FACR

Phase 2 Results for Mavrilimumab Are In

November 19, 2018 • By Mary Beth Nierengarten

TH Foto-Werbung / Science Source

Turmeric: The Evidence for Therapeutic Use for Arthritis

November 19, 2018 • By Samantha C. Shapiro, MD

1
2
3
…
17
Next Page »